Last $8.81 USD
Change Today 0.00 / 0.00%
Volume 6.0K
IRIX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 5:20 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

iridex corp (IRIX) Key Developments

IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions

IRIDEX Corporation announced that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced ophthalmology solutions to patients across vast areas of China's rural regions. Moore added that the advances in laser-based therapies are also ushering in a paradigm shift in the U.S. and European ophthalmology markets, including diabetic macular edema (DME) and glaucoma treatments.

IRIDEX Corporation Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment

IRIDEX Corporation announced that it has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.

IRIDEX Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 27, 2014; Provides Earnings Guidance for the Fourth Quarter of 2014

IRIDEX Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 27, 2014. For the quarter, the company reported net income of $490,000 or $0.05 per basic and diluted share on total revenues of $10,118,000 compared to net income of $530,000 or $0.05 per basic and diluted share on total revenues of $9,526,000 a year ago. Income from operations was $606,000 against $665,000 a year ago. Income from continuing operations before provision for income taxes was $494,000 against $580,000 a year ago. For the nine months, the company reported net income of $1,274,000 or $0.12 per diluted share on total revenues of $31,036,000 compared to net income of $1,819,000 or $0.18 per basic and diluted share on total revenues of $27,675,000 a year ago. Income from operations was $1,603,000 against $2,077,000 a year ago. Income from continuing operations before provision for income taxes was $1,303,000 against $1,877,000 a year ago. For the fourth quarter, the company expects to achieve revenue of $10.9 million to $11.2 million, which compares to revenues of $10.6 million for the 2013 fourth quarter. Gross margin is anticipated to come in between 49% and 51%, and operating expenses are expected to be $4.7 million to $4.9 million.

IRIDEX Corporation to Report Q3, 2014 Results on Oct 30, 2014

IRIDEX Corporation announced that they will report Q3, 2014 results at 5:00 PM, US Eastern Standard Time on Oct 30, 2014

IRIDEX Corporation, Q3 2014 Earnings Call, Oct 30, 2014

IRIDEX Corporation, Q3 2014 Earnings Call, Oct 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRIX:US $8.81 USD 0.00

IRIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cutera Inc $9.80 USD -0.01
Ellex Medical Lasers Ltd A$0.27 AUD 0.00
Lutronic Corp 20,400 KRW +850.00
STAAR Surgical Co $9.10 USD -0.12
Synergetics USA Inc $4.50 USD +0.22
View Industry Companies
 

Industry Analysis

IRIX

Industry Average

Valuation IRIX Industry Range
Price/Earnings 54.4x
Price/Sales 2.1x
Price/Book 3.4x
Price/Cash Flow 51.4x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRIDEX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.